Navigation Links
Women More Prone to Die in Month After Heart Attack

But factors other than gender may be to blame, researchers say

TUESDAY, Aug. 25 (HealthDay News) -- Women are more likely to die than men in the 30 days after a heart attack, but that doesn't mean gender is driving the trend, a new study finds.

Rather, "the difference can be attributed to well-known clinical and angiographic characteristics," such as age and the presence of other illnesses, said study lead author Dr. Jeffrey S. Berger, assistant professor of medicine and director of cardiovascular thrombosis at New York University.

He and his colleagues published the findings in the Aug. 26 issue of the Journal of the American Medical Association.

In the study, data on more than 136,000 people (28 percent of them women) from 11 major international studies of acute coronary syndrome showed no significant difference in male-female death rates after adjusting for clinical characteristics such as the amount of blockage in heart arteries and the presence of risk factors such as diabetes and high blood pressure, Berger said.

The analysis was done because "in many prior studies the data had been conflicting about how women do compared to men," he said. "Some would tell you women did worse, others that there were no differences. But the majority of these studies were small, done in single centers and for short periods of time. This study allowed a look at data spanning two decades that occurred all over the world."

The unadjusted data found a 9.6 percent death rate for women versus a 5.3 percent death rate for men in the 30 days after an acute coronary syndrome, which includes events such as heart attack or unstable angina. But that all changed once researchers began adjusting for various co-factors.

For example, the women in the studies were older and more likely to have high blood pressure, high blood cholesterol, diabetes and heart failure, the team noted. On the other hand, the men were more likely to be smokers, to have had a previous heart attack and to have had coronary artery bypass surgery.

When all risk factors were taken into account, "there was no sex-fixed mortality difference among those with acute coronary syndrome," Berger said.

One difference did emerge from the analysis, he said: "Not all acute coronary syndromes can be placed in a single category. There were significant differences based on severity of diagnosis."

The 30-day death rate was higher for women than men who suffered a STEMI myocardial infarction, the most severe form of heart attack. For less severe acute coronary syndromes, such as non-STEMI heart attacks and the acute chest pain called unstable angina, the 30-day death rate was significantly lower for women than men.

The study shows that what physicians call comorbidities -- other illnesses -- play a more important role in determining survival in women than in men, said Dr. Pamela S. Douglas, professor of medicine at Duke University, a member of the research team.

"What we find is that men have a higher mortality from the heart disease event while mortality in women depends more on the heart disease event plus other illnesses," Douglas said.

The finding doesn't mean that women with heart disease should be treated differently than men, but that physicians should remain aware of the importance of other illnesses in women, she said.

A second report in the same issue of the journal described a genetic variant that can limit the effectiveness of Plavix (clopidogrel), the clot-preventing drug that is commonly prescribed after artery-opening angioplasty.

A study led by physicians at the University of Maryland School of Medicine looked at the effect of a gene called CYP2C19 on the activity of platelets, the blood cells involved in clotting, among members of the Old Order Amish community. It found that those who carried one variant of the gene had a significantly lower response to Plavix therapy. Carriers of the gene variant had more than double the incidence of artery blockage or death in the year after angioplasty than noncarriers -- 20.9 percent compared to 10 percent.

The finding could lead to genetic typing to help guide Plavix therapy, the researchers wrote, but they added that "prospective randomized clinical trials will be necessary to determine the efficacy of CYP2C19 genotype-directed therapy in evidence-based clinical decision making."

More information

Advice on heart disease in women is available from the American Heart Association.

SOURCES: Pamela S. Douglas, M.D., professor, medicine, Duke University, Durham, N.C.; Jeffrey S. Berger, M.D., assistant professor, medicine, director, cardiovascular thrombosis, New York University, New York City; Aug. 26, 2009, Journal of the American Medical Association

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. More Women Surviving After Early Breast Cancer
2. Ageless, Time-tested for Enhanced Body Image Using the Color Orange Revealed at Upcoming Women Taking Care of the World Conference in St. Petersburg, FL
3. Testosterone Influences Womens Career Moves
4. Blood Mercury Levels Rising Among U.S. Women
5. Better Pap Smear Follow-Up Needed Among Lower-Income Women
6. Acupuncture may bring relief for a common condition in women
7. Women Speak Out Against Government Takeover of Health Care
8. US-born Asian-American women more likely to think about, attempt suicide
9. Journal of Midwifery & Womens Health honors outstanding authors
10. Magazines for Women Depict Babies in Unsafe Sleep Environments
11. Magazines for women depict babies in unsafe sleep environments
Post Your Comments:
Related Image:
Women More Prone to Die in Month After Heart Attack
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from reveals that behind the tendency to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology: